Researchers from Amsterdam UMC, in collaboration with other hospitals, have successfully completed the first Phase III study of an in vivo CRISPR therapy. In this large-scale, double-blind trial, 80 ...
Researchers from Amsterdam UMC, in collaboration with other hospitals, have successfully completed the first Phase III study of an in vivo CRISPR therapy. In this large-scale, double-blind trial, 80 ...
Philadelphia and Gordonville, PA, August 12, 2025 – Researchers from Children’s Hospital of Philadelphia (CHOP) and the Clinic for Special Children found that complement factor I (CFI) deficiency, an ...
Researchers from the Children's Hospital of Philadelphia (CHOP) and the Clinic for Special Children found that complement factor I (CFI) deficiency, an ultra-rare genetic disorder that can cause ...
Global biopharma company encourages education and awareness around a rare bleeding disorder. FORT LEE, N.J., Oct. 10, 2023 /PRNewswire/ -- Kedrion Biopharma, an international biopharmaceutical company ...
Credit: Getty Images. CHAPLE disease is a rare genetic disorder caused by mutations in the CD55 gene. The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License ...
WICHITA, Kan. (KSNW) — A rare genetic deficiency that can cause developmental delays, intellectual disability, seizures and movement disorders will now be part of the Kansas Department of Health and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results